Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3

European Heart Journal

5 November 2020

Organised by:

Read full article

Abstract

Abstract

Contributors

Ulf Landmesser

Ulf Landmesser

Author

Charite University Hospital Berlin , Germany

Thomas F Lüscher

Thomas F Lüscher

Author

You may be interested in

Congress Presentation

RNA interference targeting hepatic angiopoietin-like protein 3 results in prolonged reductions in serum triglyceride and non-HDL cholesterol concentrations: first human results with ARO-ANG3

25 August 2023

Webinar

Lipoprotein(a): current role and future perspectives in cardiovascular medicine

31 October 2025

Congress Presentation

RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency

31 August 2020

Congress Presentation

NFkB Interacting long non-coding RNA (NKILA) predicts major adverse cardiovascular events in the elderly

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources